|
World Vaccine Congress Asia 2009將吸引來自全球及區域性之疫苗交易業者、管理機關、投資家、技術．服務業者齊聚，共同探討亞洲各種疫苗市場之商業策略，在此將有機會可以找尋國際化所需之戰略合作伙伴。
從15個亞洲機構來了解次世代革新疫苖的最新發展動向。
在此將介紹亞洲製藥企業、生技企業、以及大學之最新疫苗開發、技術革新動向。
將有機會與亞洲10個國家以上的買家進行商談。
國際公共衛生領導人士、疾病管制當局、及管理機關齊聚，將為他們的市場判定所需之疫苗。
更新經營戰略：向亞洲排名前20之市場領導者學習。
聽取業界專家針對亞洲疫苗市場所制定之『藍海戰略』。
與疫苗買家之交流
Sanofi Pasteur, Novartis, Intercell, Indian Immunologicals, GlaxoSmithKline Biologicals, Green Cross, China National Biotec Group (CNBG), Crucell, Shantha Biotech等企業將蒞臨會議。
» Reserve your seat now
|
Are we pandemic ready? Find out at the Influenza Vaccine Summit!
The H1N1 (swine flu) has reached the shores of Asia. This is the first time the WHO had declared a Phase 5 outbreak, the second-highest on its threat scale, indicating a pandemic could be “imminent”. To date, it remains probable that the alert level would be raised from its current level of 5 to the top of the six-stage scale.
Stockpiling of anti-flu drugs is the top most priority of Asian health ministers as they prepare for the possible outbreak of H1N1 in the region. The main concerns are – whether the current stockpile is enough for the region and how quickly a vaccine can be produced in the event of an outbreak.
Join us at World Vaccine Congress Asia’s Influenza Vaccine Summit, a summit dedicated to tackle the latest developments in influenza. The program will discuss topics that include preparing for a pandemic, the seasonal flu, technologies for scale up production and many more. Leading players such as Sanofi Pasteur, GSK, CSL will participate in the summit, giving you an unprecedented opportunity to knowledge-share during these critical times.
» View the Influenza Vaccine Summit agenda
|
